New drug trial aims to stop liver cancer from coming back after treatment
NCT ID NCT06248554
Summary
This study is testing whether adding a PD-1 inhibitor drug after microwave ablation treatment can help prevent early-stage liver cancer from returning. Researchers want to see if this combination approach improves how long patients live without their cancer coming back. The study will include 200 adults with early-stage liver cancer who have recently completed microwave ablation treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
RECRUITINGWuhan, 430000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.